Staphyt has solidified its position as the leading regulatory consultancy in Brazil for the fourth consecutive year. In 2025, the company (along with its subsidiary BioRisk) assisted in 82 product registrations, representing approximately 9% of all approved agricultural products in the country.
Staphyt Leads Ag Product Registrations in Brazil for 4th Consecutive Year
Brazil – January 2026
In an increasingly technical and rigorous regulatory environment, Staphyt has once again demonstrated its market dominance. Of the 912 total product registrations granted in Brazil throughout 2025, 82 counted on the technical and regulatory support of Staphyt (approximately 9% of the total)—the highest volume among all consultancies operating in Brazil.
These results, which include registrations conducted by Staphyt’s subsidiary BioRisk, reflect a solid performance across diverse categories, including Technical Products, Formulated Products, and Biologicals.
Regulatory affairs in Brazil involve complex processes with detailed technical analyses and extended deadlines. Staphyt’s ability to sustain leadership for four years is driven by:
- Technical Specialization: Teams with deep practical experience in legislation.
- Strategic Prevention: Anticipating regulatory requirements to avoid delays.
- Complexity Management: Handling everything from technical equivalence to innovative biologicals.
Upcoming Webinar: Bioinputs Registration
As part of its commitment to sharing knowledge, Staphyt will host an exclusive webinar with Daniela Maia, Director of Regulatory Affairs (Brazil), on February 3rd at 11:00 AM (Brasília Time). The session will cover the current framework for biological products and upcoming developments regarding the new Bioinputs Law.
Leave a Reply